Anzeige
Mehr »
Login
Freitag, 24.01.2025 Börsentäglich über 12.000 News von 683 internationalen Medien
Hinter dem nuklearen Ansturm im Silicon Valley: Eine strategische Chance entsteht
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 893072 | ISIN: TRASISEW91Q3 | Ticker-Symbol:
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
TURKIYE SISE VE CAM FABRIKALARI AS Chart 1 Jahr
5-Tage-Chart
TURKIYE SISE VE CAM FABRIKALARI AS 5-Tage-Chart
GlobeNewswire (Europe)
107 Leser
Artikel bewerten:
(0)

Türkiye Sise ve Cam Fabrikalari: Sisecam's First-Half Net Sales Reached 86 Billion TRY

Finanznachrichten News

With production operations spanning 14 countries on four continents and sales in over 150 countries, Sisecam continues its global operations. In the first half of 2024, Sisecam recorded consolidated net sales of TRY 86 billion. During this period, international sales accounted for 61% of Sisecam's total sales, while the company's total investments reached TRY 11 billion and exports totaled USD 492 million.

ISTANBUL, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Sisecam announced its financial results for the first half of 2024. In this period, Sisecam's consolidated net sales totaled TRY 86 billion. International sales - the sum of exports from Türkiye and sales from production outside Türkiye - accounted for 61% of consolidated sales. Sisecam's total investments amounted to TRY 11 billion, while exports from Turkiye totaled USD 492 million. During this period, the company produced 2.7 million tons of glass, 2.3 million tons of soda ash, and 1.8 million tons of industrial raw materials.

Sisecam's CEO, Görkem Elverici, commented on the global economic and sectoral outlook in relation to the company's first-half 2024 results: "2024 began with significant global economic uncertainties and geopolitical tensions, which continued into the second quarter. The monetary policy measures implemented to control persistent high price levels globally had a considerable impact on the consumer appetite and economic growth. These measures, together with market imbalances, fluctuations in energy prices, and geopolitical tensions, impacted not only the broader business environment but also the sectors in which Sisecam operates. The continuing weak demand, along with a slowdown in some regions, further emphasized the need for cost-saving and operational efficiency measures. The ability to make agile decisions and act swiftly became increasingly critical. We believe that interest rate cuts and demand improvements in the second half of the year will partially support moderate developments in economies and a recovery in our sectors."

Regarding Sisecam's first-half 2024 results, Görkem Elverici stated: "With its experience in foreseeing uncertainties and strategic decision-making mechanisms, Sisecam successfully managed risks in the first half of the year. Consistent with its long-term strategic goals and regional strategies across business lines, Sisecam continues to manage its investment plans that create sustainable value, while taking economic and geopolitical developments into account. This strategic approach, which significantly contributes to the sustainable increase in shareholder value, will enable Sisecam to meet the anticipated demand with even stronger capabilities as uncertainties diminish and more favorable market dynamics emerge."

Global Confidence in Sisecam

Görkem Elverici also highlighted Sisecam's record-breaking bond issuance in April and May, which marks the largest corporate bond issuance in the history of the Turkish Republic: "We issued Eurobonds totaling USD 1.5 billion in two tranches - with 55% maturing in 8 years and 45% in 5 years - to international funds and financial institutions. This issuance attracted nearly USD 5 billion in total demand from international funds and financial institutions, setting a record for the largest corporate bond issuance in the history of the Turkish Republic. Additionally, leading credit rating agencies Fitch and Moody's have lifted the country ceiling on Sisecam's credit rating. These developments once again reaffirm the global confidence in Sisecam."


© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.